InsidersTradesSigma
Follow the Camlin Fine Sciences stock price and the full insider trade history of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €19.8bn. The latest transaction was reported on 7 August 2026 (Pledge). Among the most active insiders: Mr. Ashish Subhash Dandekar. All data is free.
Analysts rate Camlin Fine Sciences Buy (bullish), based on 2 analysts. Average price target: ₹152.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Camlin Fine Sciences es una empresa especializada en la fabricación de productos químicos y aditivos para diversos sectores, incluidos el alimentario y el agrícola. Cotiza en la Bolsa de Bombay.